Michael J. Chappell - researchr alias

researchr

You are not signed in
Sign in
Sign up

Viewing Publication 1 - 17 from 17

2024

Portable markerless hand motion capture system for determining the grasps performed in activities of daily livingCallum John Thornton, Michael J. Chappell, Neil D. Evans, Joseph Hardwicke. cmbbeiv, 11(7), January 2024. [doi]

2019

Three novel approaches to structural identifiability analysis in mixed-effects modelsDavid Janzén, Mats Jirstrand, Michael J. Chappell, Neil D. Evans. cmpb, 171:141-152, 2019. [doi]

Input-Dependent Structural Identifiability of Nonlinear SystemsAlejandro Fernández Villaverde, Neil D. Evans, Michael J. Chappell, Julio R. Banga. csysl, 3(2):272-277, 2019. [doi]

2016

Development of a Handheld Side-Stream Breath Analyser for Point of Care Metabolic Rate MeasurementT. A. Vincent, A. Wilson, J. G. Hattersley, Michael J. Chappell, J. W. Gardner. iwbbio 2016: 13-21 [doi]

2014

Structural identifiability analyses of candidate models for in vitro Pitavastatin hepatic uptakeThomas R. B. Grandjean, Michael J. Chappell, James W. T. Yates, Neil D. Evans. cmpb, 114(3), 2014. [doi]

Reprint of "Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin"Adam J. Hall, Michael J. Chappell, John A. D. Aston, Stephen A. Ward. cmpb, 114(3), 2014. [doi]

2013

The input-output relationship approach to structural identifiability analysisDaniel J. Bearup, Neil D. Evans, Michael J. Chappell. cmpb, 109(2):171-181, 2013. [doi]

Structural identifiability of surface binding reactions involving heterogeneous analyte: Application to surface plasmon resonance experimentsNeil D. Evans, H. A. J. Moyse, D. Lowe, D. Briggs, R. M. Higgins, D. Mitchell, D. Zehnder, Michael J. Chappell. automatica, 49(1):48-57, 2013. [doi]

Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisininAdam J. Hall, Michael J. Chappell, John A. D. Aston, Stephen A. Ward. cmpb, 112(1):1-15, 2013. [doi]

Describing the effectiveness of immunosuppression drugs and apheresis in the treatment of transplant patientsJ. G. Hattersley, Michael J. Chappell, D. Zehnder, R. M. Higgins, Neil D. Evans. cmpb, 109(2):126-133, 2013. [doi]

2011

Kinetic modelling of the role of the aldehyde dehydrogenase enzyme and the breast cancer resistance protein in drug resistance and transportM. I. Atari, Michael J. Chappell, Rachel J. Errington, Paul J. Smith, Neil D. Evans. cmpb, 104(2):93-103, 2011. [doi]

The use of a formal sensitivity analysis on epidemic models with immune protection from maternally acquired antibodiesJ. D. Chapman, Michael J. Chappell, Neil D. Evans. cmpb, 104(2):37-49, 2011. [doi]

Compartmental modelling of the pharmacokinetics of a breast cancer resistance proteinThomas R. B. Grandjean, Michael J. Chappell, James T. W. Yates, Kevin Jones, Gemma Wood, Tanya Coleman. cmpb, 104(2):81-92, 2011. [doi]

Indistinguishability and identifiability of kinetic models for the MurC reaction in peptidoglycan biosynthesisJ. G. Hattersley, J. Pérez-Velázquez, Michael J. Chappell, Daniel J. Bearup, D. Roper, C. Dowson, T. Bugg, Neil D. Evans. cmpb, 104(2):70-80, 2011. [doi]

A new general glucose homeostatic model using a proportional-integral-derivative controllerE. M. Watson, Michael J. Chappell, F. Ducrozet, S. M. Poucher, James W. T. Yates. cmpb, 102(2):119-129, 2011. [doi]

2009

Structural identifiability analysis via symmetries of differential equationsJames W. T. Yates, Neil D. Evans, Michael J. Chappell. automatica, 45(11):2585-2591, 2009. [doi]

2002

Identifiability of uncontrolled nonlinear rational systemsNeil D. Evans, Michael J. Chapman, Michael J. Chappell, K. R. Godfrey. automatica, 38(10):1799-1805, 2002. [doi]

Sign in or sign up to see more results.

runs on WebDSL